Comparison of Results of Operations Between the Three Months Ended March 31, 2009 and 2008.
Revenue, principally license fee revenue: the company recorded $2,466,670 in revenue during the first quarter of 2009, as compared to $951,787 in revenue during the first quarter of 2008.
Research and Development Expenses: the company research and development expenses for the first quarters of 2009 and 2008 were $602,366 and $1,169,091, respectively.
General and Administrative Expenses: the company general and administrative expenses were $1,091,047 during the first quarter of 2009 as compared to $1,303,398 during the same period in 2008.
Interest Expense, Net: the company had net interest expense of $88,485 during the first quarter of 2009, as compared to $121,485 during the same period in 2008.
NexMed is a pharmaceutical and medical technology company with a focus on developing and commercializing therapeutic products based on its delivery systems.
